Concept: A randomised multicentre trial of first line chemotherapy comparing three weekly cabazitaxel versus weekly paclitaxel in HER2 negative metastatic breast cancer
Bahl, Amit, Wilson, William, Ball, Jessica, Renninson, Emily, Dubey, Sidharth, Bravo, Alicia, Foulstone, Emily, Spensley, Saiqa, Bowen, Rebecca, Mansi, Janine, Waters, Simon, Riddle, Pippa, Wheatley, Duncan, Stephens, Peter, Bezecny, Pavel, Madhusudan, Srinivasan, Verrill, Mark, Braybrooke, Jeremy, Comins, Charles, Mohan, Vivek, Gee, Abigail, Kirk, Hannah, Markham, Alison, Evans, Heidi, Watson, Eve, Callaway, Mark, Pearson, Sylvia, Hackshaw, Allan, Churn, Mark
Published in Breast (Edinburgh) (01.12.2022)
Published in Breast (Edinburgh) (01.12.2022)
Get full text
Journal Article
Incidence of febrile neutropenia in docetaxel chemotherapy without prophylactic granulocyte-colony stimulating factor (GCSF) for metastatic prostate cancer
Renninson, Emily, Closier, Philippa, Jonnada, Sai
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.09.2018)
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.09.2018)
Get full text
Journal Article
A phase II trial of cemiplimab alone or in combination with standard of care chemotherapy in locally advanced or metastatic penile carcinoma (EPIC trial)
Bahl, Amit, Foulstone, Emily, Ashurst, Lauren, Renninson, Emily, White, Paul, Bravo, Alicia, Afshar, Mehran, Alifrangis, Constantine, Venugopal, Balaji, Thomson, Alastair, Tran, Anna, Barber, Jim, Dearden, Helen Clare, Kent, Christopher, Kumar, Vivekanandan, Callaway, Mark, Challapalli, Amarnath
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Multi-centre prospective evaluation of cognitive function in patients with metastatic castrate-resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) or enzalutamide (ENZ): The ACE study
Bahl, Amit, Challapalli, Amarnath, Birtle, Alison Jane, Foulstone, Emily, Renninson, Emily, Ashurst, Lauren, Bravo, Alicia, Parikh, Omi, Sankey, Peter, Maund, Isabella, Srinivasan, Rajaguru, Das, Prantik, Ratnayake, Gihan, Gray, Emma, Varughese, Mohini, Tran, Anna, Clarke, Noel, McGovern, Ursula, Needleman, Sarah, White, Paul
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
The Bristol Bladder Trial: Five year outcomes in patients treated with neoadjuvant cabazitaxel and cisplatin chemotherapy for muscle invasive transitional cell carcinoma of the urinary bladder
Challapalli, Amarnath, White, Paul, Masson, Susan, Foulstone, Emily, Renninson, Emily, Bravo, Alicia, Pearson, Sylvia, Dailami, Narges, Persad, Raj, Koupparis, Anthony, Rowe, Edward, Oxley, Jon, Kabala, Julian, Ash-Miles, Janice, Bahl, Amit
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Real world prospective evaluation of clinical outcomes in patients with non-metastatic castrate resistant prostate cancer treated with darolutamide
Challapalli, Amarnath, Renninson, Emily, White, Paul, Elumalai, Thiraviyam, Parikh, Omi, Vickers, Alexander, Birtle, Alison Jane, Brocklehurst, Andrew, Bhana, Rajanee, Wickramasinghe, Kanchana, Jayaprakash, Kamalram Thippu, Gray, Emma, Sephton, Matthew, Bowzyk Al-Naeeb, Anna, Foulstone, Emily, Soundy, Alexandra, Ashurst, Lauren, Bahl, Amit
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
A phase II trial of cemiplimab alone or in combination with standard of care chemotherapy in locally advanced or metastatic penile carcinoma (EPIC Trial)
Renninson, Emily, Challapalli, Amarnath, Foulstone, Emily, Bravo, Alicia, Soundy, Alexandra, Callaway, Mark, Thomson, Alastair, Alifrangis, Constantine, Afshar, Mehran, Tran, Anna, Venugopal, Balaji, White, Paul, Cano, Emil, Sharma, Anand, Bahl, Amit
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article